Patent ID: 9321733
Filing Date: 2016-04-26
CPC Classification: A61P,C07D

Claim Text:
1. A crystalline Form V rosuvastatin zinc (2:1) salt [hemizinc salt of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3R,5S)-dihydroxy-hept-6-enoic acid] of Formula (I) which has X-ray diffraction lines measured by CuKα radiation at the following diffraction angle 2Θ (±0.2° 2Θ): 4.746 degrees; or X-ray diffraction lines measured by CuKα radiation at the following diffraction angles 2Θ (±0.2° 2Θ): 4.746 and 15.371 degrees; or a powder X-ray diffractogram of or the following X-ray diffraction lines measured by the CuKα radiation: